MedPath

Multiform-based Baduanjin Exercise Prescription for Idiopathic Pulmonary Fibrosis disease (IPF) : study protocol for a randomized controlled trial

Phase 1
Conditions
Idiopathic Pulmonary Fibrosis disease
Registration Number
ITMCTR2200005533
Lead Sponsor
Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) age between 35 and 80;
(2) The clinical symptoms were stable in the last two months;
(3) Patients diagnosed with IPF who satisfied the diagnostic criteria of ATS/ERS/JRS/ALAT 2018 [According to past medical history, laboratory tests and HRCT (typical UIP and Probable UIP)];
(4) Have not participated in other sports training systematically or intermittently in the last six months (no more than twice a week);
(5) No other disabling diseases (e.g. stroke, Parkinson's disease, etc.);
(6) Patients who agree to sign written informed consent.

Exclusion Criteria

(1) other chronic respiratory diseases;
(2) serious complications, including cardiovascular, liver or kidney disease;
(3) Inpatients whose condition is rapidly aggravating or in urgent need of other medication management;
(4) Skeletal muscle diseases or other diseases that may affect muscle strength assessment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pulmonary function;Six minutes walking distan (6MWD);HRCT change (HRCT score);
Secondary Outcome Measures
NameTimeMethod
St. George Respiratory Questionnaire (SGRQ);modified British Medical Research Council (mMRC);
© Copyright 2025. All Rights Reserved by MedPath